💨 Abstract
Intas Pharmaceuticals Limited has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency, recommending approval for HETRONIFLY® (serplulimab) in European markets.
Courtesy: theprint.in
Summarized by Einstein Beta 🤖
Suggested
Gender gap in agriculture: CIWA official calls for data-driven policies, financial inclusion
Exclusive-Russia has secret war drones project in China, intel sources say
Peace on border must for progress in India-China ties; ‘parallel rise’ of two nations presents unique problem: Jaishankar
Journalist exposes Pakistan's role in spreading terrorism across Asia and Africa
'Saudi Welcome to Arabia' rolls out the lavender carpet for India, at 'Spectacular Saudi' in Mumbai
Dancing videos of Modi, Mahatama Gandhi posted on social media; case filed
Peace on border must for progress in India-China ties; ‘parallel rise’ of two nations presents unique problem: Jaishankar
BJD calls BJP 'anti-tribal', slams Odisha govt for stopping schemes
3-year-old boy stabbed to death in Bihar, one held
Seoul launches Korea's first nighttime self-driving taxi service
Powered by MessengerX.io